Company Search:
Advanced Search
Sponsored Links
Mayne Pharma Group Limited Company Snapshot
Mayne Pharma Group Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mayne Pharma Group Limited with three other pharmaceutical manufacturers in Australasia: AFT Pharmaceuticals Ltd of New Zealand (2016 sales of 64.01 million New Zealand Dollars [US$45.79 million] of which 100% was Pharmaceutical), Probiotec Limited (65.61 million Australian Dollars [US$49.93 million] ), and Acrux Ltd (28.56 million Australian Dollars [US$21.73 million] ).

Sales Analysis. During the year ended June of 2016, sales at Mayne Pharma Group Limited were A$267.28 million (US$203.41 million). This is an increase of 89.0% versus 2015, when the company's sales were A$141.42 million. Sales of Metrics Contract Services (Mcs) saw an increase of 44.7% in 2016, from A$33.79 million to A$48.89 million. Not all segments of Mayne Pharma Group Limited experienced an increase in sales in 2016: sales of Mayne Pharma International (Mpi) fell 44.4% to A$33.74 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mayne Pharma Group Limited
  Stock Performance Chart for Mayne Pharma Group Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 1.77
(Figures in Australian Dollars)
1 Week -5.6%   13 Weeks -13.2%  
4 Weeks -8.3%   52 Weeks 82.2%  
Mayne Pharma Group Limited Key Data:
  Ticker: MYX Country: Australia
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 267,280,000
(Year Ending Jan 2017).
Employees: 160
  Currency: Australian Dollars Market Cap: 1,433,782,032
  Fiscal Yr Ends: June Shares Outstanding: 810,046,346
  Share Type: Units Closely Held Shares: 167,094,072
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.